Herbal Ecstacy "safe," "no side effect" claims will be halted under FTC settlement.
This article was originally published in The Tan Sheet
HERBAL ECSTACY "SAFE", "NO SIDE EFFECTS" CLAIMS WILL BE HALTED under a settlement agreement between the Federal Trade Commission and Venice, Calif.-based Global World Media Corp. and its owner, Sean Shayan, announced July 29. All future advertising and promotions for the ephedra (ma huang)-containing dietary supplement must be truthful and warn consumers of the potentially serious side effects associated with ephedra, the settlement states. Global Media and Shayan also have agreed to "refrain from promoting Ecstacy or any similar product for its mind-altering effects in media with a predominant youth audience" (50% or more under age 21).
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC